About: Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
Creator	Zhang, Wei Xiong, Wei Jiang, Li Chen, Dechang Shang, You Yu, Zhui Zhong, Ming Liu, Jiao Pan, Chun Sang, Ling Shang, Xiuling Wu, Zhixiong Yang, Xianghong Zhang, Jiancheng Zheng, Xia Zhong, Qiang
source	Medline; PMC
abstract	BACKGROUND: The ongoing coronavirus disease 2019 (COVID-2019) pandemic has swept all over the world, posing a great pressure on critical care resources due to large number of patients needing critical care. Statements from front-line experts in the field of intensive care are urgently needed. METHODS: Sixteen front-line experts in China fighting against the COVID-19 epidemic in Wuhan were organized to develop an expert statement after 5 rounds of expert seminars and discussions to provide trustworthy recommendation on the management of critically ill COVID-19 patients. Each expert was assigned tasks within their field of expertise to provide draft statements and rationale. Parts of the expert statement are based on epidemiological and clinical evidence, without available scientific evidences. RESULTS: A comprehensive document with 46 statements are presented, including protection of medical personnel, etiological treatment, diagnosis and treatment of tissue and organ functional impairment, psychological interventions, immunity therapy, nutritional support, and transportation of critically ill COVID-19 patients. Among them, 5 recommendations were strong (Grade 1), 21 were weak (Grade 2), and 20 were experts’ opinions. A strong agreement from voting participants was obtained for all recommendations. CONCLUSION: There are still no targeted therapies for COVID-19 patients. Dynamic monitoring and supportive treatment for the restoration of tissue vascularization and organ function are particularly important.
has issue date	2020-06-06(xsd:dateTime)
bibo:doi	10.1186/s13613-020-00689-1
bibo:pmid	32506258
has license	cc-by
sha1sum (hex)	756600919dd9d0c13b260fc2766f2b9c9ba48c11
schema:url	https://doi.org/10.1186/s13613-020-00689-1
resource representing a document's title	Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
has PubMed Central identifier	PMC7275657
has PubMed identifier	32506258
schema:publication	Ann Intensive Care
resource representing a document's body	covid:756600919dd9d0c13b260fc2766f2b9c9ba48c11#body_text
is schema:about of	named entity 'China' named entity 'Background' named entity 'intensive care' named entity 'ECMO' named entity 'epidemic' named entity 'secondary infection' named entity 'prone position' named entity 'COVID-19' named entity 'extracorporeal life support' named entity 'Convalescent plasma therapy' named entity 'pharmacotherapy' named entity 'diabetes' named entity 'clinical trials' named entity 'virus infections' named entity 'enteral nutrition' named entity 'critically ill patients' named entity 'pulmonary arterial hypertension' named entity 'comorbidities' named entity 'invasive mechanical ventilation' named entity 'COVID-19' named entity 'triage' named entity 'deep sedation' named entity 'hypoxemic' named entity 'fondaparinux' named entity 'ARDS' named entity 'hand hygiene' named entity 'murine' named entity 'long-term' named entity 'fibrinogen' named entity 'hypoxemia' named entity 'sedation' named entity 'protein synthesis' named entity 'COVID-19 pandemic' named entity 'albumin' named entity 'ICU' named entity 'COVID' named entity 'deep sedation' named entity 'influenza' named entity 'comorbidities' named entity 'VTE' named entity 'COVID' named entity 'RASS' named entity 'cardiac output' named entity 'SARS-CoV' named entity 'World Health Organization' named entity 'ECMO' named entity 'tracheal intubation' named entity 'parenteral nutrition' named entity 'anxiety' named entity 'cross-sectional survey' named entity 'intensive care' named entity 'ARDS' named entity 'face shields' named entity 'APTT' named entity 'Deep sedation' named entity 'ventilator-induced lung injury' named entity 'endotracheal intubation' named entity 'ritonavir' named entity 'coagulation' named entity 'CRRT' named entity 'chronic respiratory disease' named entity 'diarrhea' named entity 'tissue perfusion' named entity 'thrombocytopenia' named entity 'transfusion' named entity 'fluid resuscitation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software